Basu Chakrabarty

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Neurourology and urodynamics

British journal of pharmacology

BJU international

The Journal of pathology

University of Bristol

Monash University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bristol

United Kingdom

Research Associate :: School of Physiology, Pharmacology, and Neuroscience

Education History

Monash University

Australia

PHD :: Drug Discovery Biology

Monash University

Australia

BSC :: Pharmaceutical Biology

Monash University

Australia

BSC :: Formulation Chemistry

Publications

Anthony J Kanai, Basu Chakrabarty, Michael Winder, Hashim Hashim, Alan Wein, Paul Abrams, Christopher Henry Fry
New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023. Neurourology and urodynamics (2023)
Luke Grundy, Jean-Jacques Wyndaele, Hikaru Hashitani, Bahareh Vahabi, Alan Wein, Paul Abrams, Basu Chakrabarty, Christopher Henry Fry
How does the lower urinary tract contribute to bladder sensation? ICI-RS 2023. Neurourology and urodynamics (2023)
Basu Chakrabarty, Michael Winder, Anthony J Kanai, Hikaru Hashitani, Marcus J Drake, Paul Abrams, Christopher Henry Fry
Nitric oxide signaling pathways in the normal and pathological bladder: Do they provide new pharmacological pathways?-ICI-RS 2023. Neurourology and urodynamics (2023)
Basu Chakrabarty, Marcus J Drake, Anthony J Kanai, Christopher Henry Fry
Selective reduction of neurotransmitter release by cAMP-dependent pathways in mouse detrusor. American journal of physiology. Regulatory, integrative and comparative physiology 323 (6) (2022)
Irina V Zabbarova, Youko Ikeda, Mark G Kozlowski, Pradeep Tyagi, Lori Ann Birder, Basu Chakrabarty, Subashan Kpg Perera, Rajiv Dhir, Adam C Straub, Peter Sandner, Karl-Erik Andersson, Marcus J Drake, Christopher Henry Fry, Anthony J Kanai
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. The Journal of pathology 256 (4) (2022)
Basu Chakrabarty
The role of the bladder urothelium as a chemical-neural transducer via purinergic signalling in the rapid defence against bacterial infection. Purinergic signalling 17 (3) (2021)
Nobuyuki Nishikawa, Basu Chakrabarty, Darryl Kitney, Rita Jabr, Anthony J Kanai, Christopher Henry Fry
Stretch- and carbachol-induced ATP release from bladder wall preparations of young and aged mice. Neurourology and urodynamics 39 (6) (2020)
Christopher Henry Fry, Basu Chakrabarty, Hikaru Hashitani, Karl-Erik Andersson, Karen D McCloskey, Rita I Jabr, Marcus J Drake
New targets for overactive bladder-ICI-RS 2109. Neurourology and urodynamics (2019)
Carly J McCarthy, Youko Ikeda, Deborah Skennerton, Basu Chakrabarty, Anthony J Kanai, Rita I Jabr, Christopher Henry Fry
Characterisation of nerve-mediated ATP release from bladder detrusor muscle and its pathological implications. British journal of pharmacology 176 (24) (2019)
Basu Chakrabarty, Hiroki Ito, Manuela Ximenes, Nobuyuki Nishikawa, Bahareh Vahabi, Anthony J Kanai, Anthony Edward Pickering, Marcus J Drake, Christopher Henry Fry
Influence of sildenafil on the purinergic components of nerve-mediated and urothelial ATP release from the bladder of normal and spinal cord injured mice. British journal of pharmacology 176 (13) (2019)
Hiroki Ito, Basu Chakrabarty, Marcus J Drake, Christopher H Fry, Anthony J Kanai, Anthony E Pickering
Sildenafil, a phosphodiesterase type 5 inhibitor, augments sphincter bursting and bladder afferent activity to enhance storage function and voiding efficiency in mice. BJU international 124 (1) (2019)

Basu Chakrabarty.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Basu Chakrabarty